Jennifer Kahn’s ‘love GMOs’ article in NYT is propaganda, not journalism
By Stacy Malkan,
U.S. Right to Know
| 07. 21. 2021
Next week in Rome, world leaders will gather to discuss how to fix the food system amid one of the worst hunger crises in recent times. According to a new United Nations report on hunger, more than 2.37 billion people did not have adequate access to food in 2020. The Covid-19 pandemic has exposed weaknesses in food systems that were already failing to meet the needs of so many people.
Rather than addressing systemic solutions for hunger and poverty, however, leaders of the upcoming UN Food Systems Summit are ignoring human rights and pushing to expand genetic engineering and commodity crop monocultures that are deepening the crises and also not feeding the world, according to hundreds of groups that are boycotting next week’s events and organizing a counter summit.
All this context is missing from a 7,000 plus word promotional article for genetically engineered foods published this week in the New York Times Magazine. Jennifer Kahn reports that, “overblown fears have turned the public against genetically modified food” even though the “potential benefits have never been greater.”...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...